Florence, SC, United States of America

John Lang

This inventor holds 1 USPTO granted patent. Top assignee: Biocryst Pharmaceuticals, Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Lang. Retrieved from https://idiyas.com/inventor/john-lang-o2hhzg5u

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: John Lang - Innovator in Pharmaceutical Salts

Introduction

John Lang is a notable inventor based in Florence, SC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. His work focuses on creating useful pharmaceutical salts that can enhance the efficacy of medications.

Latest Patents

John Lang holds 1 patent for his invention titled "Useful pharmaceutical salts of 7-[(3R, 4R)-3-Hydroxy-4-hydroxymethyl-pyrrolidin-1-ylmethyl]-3, 5-dihydro-pyrrolo [3, 2-D] pyrimidin-4-one." This patent provides novel hemi- and mono-salts of the compound with various organic and inorganic acids. The disclosure outlines methods for preparing these salts, emphasizing the use of C4 organic diacids. The innovative approach allows for the selection of hemi-salts with desired properties by varying the proportion of acids used.

Career Highlights

John Lang is currently associated with Biocryst Pharmaceuticals, Inc., where he continues to advance his research in pharmaceutical innovations. His work has the potential to impact the development of new therapeutic agents significantly.

Collaborations

John collaborates with Gary Bartley, contributing to the innovative environment at Biocryst Pharmaceuticals, Inc. Their combined expertise fosters advancements in pharmaceutical research.

Conclusion

John Lang's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to enhancing medication efficacy. His work continues to pave the way for future developments in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…